Contact
Please use this form to send email to PR contact of this press release:
Artizan Biosciences Closes $11 Million Series A-2 Financing and Enters Option and License Agreement with Biohaven Therapeutics
TO:
Please use this form to send email to PR contact of this press release:
Artizan Biosciences Closes $11 Million Series A-2 Financing and Enters Option and License Agreement with Biohaven Therapeutics
TO: